|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2009-6-12
|
|
pubmed:abstractText |
To investigate the safety and tolerability of pardoprunox (SLV308), a novel partial dopamine agonist, as an adjunct to levodopa in patients with advanced Parkinson's disease, using two titration schedules.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1421-9913
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2009 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
62
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
40-8
|
|
pubmed:meshHeading |
pubmed-meshheading:19407454-Aged,
pubmed-meshheading:19407454-Benzoxazoles,
pubmed-meshheading:19407454-Chemotherapy, Adjuvant,
pubmed-meshheading:19407454-Dopamine Agonists,
pubmed-meshheading:19407454-Double-Blind Method,
pubmed-meshheading:19407454-Female,
pubmed-meshheading:19407454-Humans,
pubmed-meshheading:19407454-Levodopa,
pubmed-meshheading:19407454-Male,
pubmed-meshheading:19407454-Middle Aged,
pubmed-meshheading:19407454-Multivariate Analysis,
pubmed-meshheading:19407454-Parkinson Disease,
pubmed-meshheading:19407454-Piperazines,
pubmed-meshheading:19407454-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Safety and tolerability of pardoprunox, a new partial dopamine agonist, in a randomized, controlled study of patients with advanced Parkinson's disease.
|
|
pubmed:affiliation |
University of South Florida, Tampa, FL 33606, USA. rhauser@hsc.usf.edu
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
